is the tirzepatide shortage over FDA Says of GLP-1 GLP-1 Drugs: FDA Sued Over

Active eating disorder If you are managing binge eating disorder or another eating disorder that tirzepatide has helped control, stopping the medication requires coordination with a mental health professional who specializes in eating disorders

If you have a sensitive stomach, taking it with a light snack is also fine

But roughly 10% to 15% of patients in those trials were nonresponders who lost less than 5% of their body weight

Pancreatitis - GLP-1 medications are associated with potential pancreatic inflammation

Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients